HomeOXBDF • OTCMKTS
add
Oxford BioMedica plc
Nakaraang pagsara
$5.20
Sakop ng taon
$2.09 - $5.68
Market cap
449.64M GBP
Average na Volume
692.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 25.40M | 17.99% |
Gastos sa pagpapatakbo | 24.35M | -33.45% |
Net na kita | -16.24M | 32.26% |
Net profit margin | -63.94 | 42.59% |
Kita sa bawat share | — | — |
EBITDA | -11.12M | 38.86% |
Aktuwal na % ng binabayarang buwis | -1.86% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 81.41M | -37.10% |
Kabuuang asset | 244.97M | -38.92% |
Kabuuang sagutin | 173.75M | -14.37% |
Kabuuang equity | 71.22M | — |
Natitirang share | 105.30M | — |
Presyo para makapag-book | 8.25 | — |
Return on assets | -15.68% | — |
Return on capital | -21.16% | — |
Cash Flow
Net change in cash
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -16.24M | 32.26% |
Cash mula sa mga operasyon | -19.60M | -624.03% |
Cash mula sa pag-invest | 3.64M | 308.64% |
Cash mula sa financing | 4.89M | 241.93% |
Net change in cash | -11.15M | -88.17% |
Malayang cash flow | -7.49M | 34.31% |
Tungkol
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Itinatag
1995
Website
Mga Empleyado
834
